Literature DB >> 32371115

German Endoscopy Unit Preparations for the Coronavirus Disease 2019 Pandemic: A Nationwide Survey.

Jakob Garbe1, Stephan Eisenmann1, Steffen Walter2, Frank Lammert3, Kaid Darwiche4, Jonas Rosendahl5.   

Abstract

Entities:  

Keywords:  COVID-19; Endoscopy Units; Personal Protective Equipment; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32371115      PMCID: PMC7194040          DOI: 10.1053/j.gastro.2020.04.061

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
The ongoing coronavirus disease 2019 (COVID-19) pandemic is a challenge for patients, health care professionals, and populations worldwide. Endoscopy units and their staff are at high risk to be exposed to and distribute the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, guidance on endoscopic activity in this pandemic is urgently needed. Recommendations must balance safety issues and practicability and, therefore, need to be cross validated by real-world data and updated as new findings emerge. To address the need for guidance in this situation, the European Society for Gastrointestinal Endoscopy (ESGE) and the German Respiratory Society (DGP) have published recommendations for endoscopy units to mitigate infection risks. To date, it is unclear whether these recommendations can be implemented in the majority of endoscopy units, because data are scarce and limited to few centers. We conducted this survey to explore the ability to implement these recommendations. As such, our data provide a basic framework for future recommendations.

Methods

Based on the ESGE and DGP recommendations, we developed 33 questions to assess the adherence to and practicability of the guidelines in an Internet-based survey. Completion of the survey was possible for 7 days from April 1 to April 7. Further details of the methodology are described in the supplementary material.

Results

Overall, 676 complete questionnaires were retrieved, of which 20 were identified as duplicates or from outside Germany and excluded. In total, 393 endoscopy units were from hospitals, and 263 were from outpatient clinics and practices from all parts of Germany (Supplementary Figure 1). Overall, 145 (22.1%) responses did not include the postal code. Supplementary Table 1 summarizes the results in detail.
Supplementary Figure 1

Geographic heatmap of COVID-19 incidence rates in federal states on April 7, 2020, and participating endoscopy units. Nationwide incidence was 119 of 100,000 inhabitants on April 7. Of note, 145 anonymous responses (22.1% of all responses) are not plotted. COVID-19 data were retrieved from the Robert Koch Institute, Germany.

Supplementary Table 1

Condensed Survey Results by Type of Endoscopy Unit

n (%)Type of endoscopy, n (%)
InterdisciplinaryBronchoscopyGastrointestinal
Responses656 (100)113 (17.2)105 (16)438 (66.7)
Cancellations
 None or <20%128 (19.5)15 (13.3)34 (32.3)79 (18.1)
 >20% to <40%125 (19.1)16 (14.2)17 (16.2)92 (21)
 >40% to <60%177 (27)43 (38.1)25 (23.8)109 (24.9)
 >60% to 100%225 (34.3)39 (34.5)29 (27.6)157 (35.8)
Measures applied
 Separation and structural conditionsa
 Ideal15 (2.3)5 (4.4)5 (4.8)5 (1.1)
 Complete118 (18)25 (22.1)23 (21.9)70 (16)
 Partial308 (47)62 (54.9)44 (41.9)202 (46.1)
 None215 (32.8)21 (18.6)33 (31.4)161 (36.8)
 Staff
 Availability of second team261 (39.8)57 (50.4)57 (54.3)147 (33.6)
 Routine staff swabs36 (5.5)9 (8)10 (9.5)17 (3.9)
 Identification of staff at risk299 (45.6)70 (61.9)52 (49.5)177 (40.4)
 Special deployment of staff at risk252 (84.3)56 (80)40 (76.9)156 (88.1)
 Infectiology consultation404 (61.6)94 (83.2)85 (81)225 (51.4)
 Procedural measures
 Patient risk assessment599 (91.3)104 (92)100 (95.2)395 (90.2)
 Swabs on patients99 (15.1)28 (24.8)34 (32.4)37 (8.4)
 Risk adapted PPE use558 (85.1)107 (94.7)89 (84.8)362 (82.6)
 COVID-19 staff training584 (89)105 (92.9)96 (91.4)383 (87.4)
 Structured follow-up59 (9)11 (9.7)11 (10.5)37 (8.4)
Expectations for the future
 Shortages of PPE
 (Highly) probable533 (81.3)86 (76.1)78 (74.2)369 (84.3)
 No opinion18 (2.7)7 (6.2)4 (3.8)7 (1.6)
 (Highly) improbable105 (16)20 (17.7)23 (21.9)62 (14.2)
 Shortages of staff
 (Highly) probable451 (68.8)73 (64.6)71 (67.7)307 (70.1)
 No opinion40 (6.1)4 (3.5)8 (7.6)28 (6.4)
 (Highly) improbable165 (25.2)36 (31.9)26 (24.8)103 (23.5)
 Financial losses threatening economic survival
 (Highly) probable508 (77.4)85 (75.2)66 (62.8)357 (81.5)
 No opinion37 (5.6)7 (6.2)9 (8.6)21 (4.8)
 (Highly) improbable111 (16.9)21 (18.6)30 (28.6)60 (13.7)

Ideal separation was given when, aside from full spatial separability, endoscopic procedures were performed in a separated negative pressure room.

Cancellations of Interventions

A total of 253 (38.6%) endoscopy units cancelled less than 40%, whereas 225 (34.3%) cancelled more than 60% of their procedures (Figure 1 ). Interestingly, 45.6% of private practices cancelled less than 40% of their procedures, compared to 33.8% of hospital-based units.
Figure 1

Survey results of 656 responses. (A) Cancelled procedures by level of care. University hospitals and maximum care facilities (n = 98), general and basic care hospitals (n = 295), and outpatient clinics and private practices (n = 263). (B) Realization of endoscopic societies’ recommendations. A mean is given for procedural measures consisting of the structured risk assessment for patients (n = 599), risk-adapted use of PPE (n = 558), and training of staff to treat patients with COVID-19 (n = 584). (C) Expectations of endoscopy unit heads for the future concerning shortages in PPE and staff as well as financial losses threatening the economic survival of the unit.

Survey results of 656 responses. (A) Cancelled procedures by level of care. University hospitals and maximum care facilities (n = 98), general and basic care hospitals (n = 295), and outpatient clinics and private practices (n = 263). (B) Realization of endoscopic societies’ recommendations. A mean is given for procedural measures consisting of the structured risk assessment for patients (n = 599), risk-adapted use of PPE (n = 558), and training of staff to treat patients with COVID-19 (n = 584). (C) Expectations of endoscopy unit heads for the future concerning shortages in PPE and staff as well as financial losses threatening the economic survival of the unit.

Separation of Patients at Risk

Ideal conditions for the separation of infectious patients were achieved in only 2.3% of endoscopies (n = 15), where a complete spatial separation and a negative pressure endoscopy suite were available. A complete or ideal separation was possible in 20.3% of the investigated endoscopy units (Figure 1). In general, most units were not able to separate well: 47% could separate only partially (peri-interventional area or endoscopy room), and 32.8% could not separate high-risk patients or those with proven COVID-19 at all.

Procedural Measures

Most endoscopy units (91.6%) identified patients at risk of infection in a structured manner. To mitigate risk of infection, most endoscopy units (>85%) issued new instructions on risk-adapted personal protective equipment (PPE) use and trained their staff in the treatment of patients with COVID-19.

Swabs

Routine swabs for personnel were performed in 5.5% of endoscopy units. Also, the overall rate of preinterventional swabs for patients was low (15.1%). Bronchoscopy units had a considerably higher rate of preinterventional swabs (32.4%) compared to gastrointestinal (GI) units (8.4%).

Expectations

The majority of endoscopy units (81.3%) perceived shortages in PPE as likely or very likely (Figure 1). Overall, 68.8% of endoscopy units expected staff shortages during the pandemic. In total, 77.4% of endoscopy units anticipated substantial financial losses that could threaten the economic survival to be likely or very likely.

Discussion

To our knowledge, this is the first nationwide survey to obtain real-world data on how endoscopy units cope with the current COVID-19 pandemic and the measures taken to ensure continued balanced patient care. The framework of this survey relied on the ESGE and DGP recommendations, both of which were published 14 days before the survey was conducted. In recent reports, the prevalence of GI symptoms in patients with SARS-CoV-2 infection was higher than previously estimated, ranging from 11.4% to 61.1% in a series with a special focus on GI symptoms. , Moreover, there is emerging evidence that SARS-CoV-2 is excreted in the feces, even after it becomes undetectable in the pharynx and lung. Furthermore, live virus was detected in the stool of patients. , As a consequence of the current knowledge, endoscopy societies have recommended postponing or cancelling all but emergency and urgent endoscopic interventions. Our results show that approximately one third of the participating endoscopy units followed these recommendations, because more than 60% of all procedures were cancelled. However, approximately 40% of the endoscopy units still performed more than 60% of their procedures. Interestingly, units performing >60% of procedures were more likely to be private practices (Figure 1). In their comments, heads of outpatient GI units repeatedly pointed out the ethical dilemma because their economic survival is threatened by cancellations. Therefore, strategies to substitute for financial losses endangering economic survival need to be discussed and implemented, particularly for privately owned endoscopy units worldwide. Of note, the British Society of Gastroenterology published a list of specific interventions and indications to guide planning and cancellations, as did the American Gastroenterological Association, which might serve as a model in this context. , It is important to note that only 20.3% of all endoscopy units had the capability to conduct interventions of high-risk patients in a spatially separated endoscopy ward. Ideal conditions, with a negative pressure endoscopy room, were an exception. Because pandemics are irregularly recurring events, these observations should be taken into consideration when new endoscopy units are planned in the future and when emergency plans are updated. Procedural measures were implemented well, such as risk stratification of patients, risk-adapted use of PPE, and training of staff to treat patients with suspected or proven COVID-19. In contrast, routine follow-up to inquire about symptoms and swabs on patients was rarely conducted. Again, all of these measurements need to be evaluated for their effectiveness in the future. Finally, fear is evident among many endoscopists that a lack of PPE might further complicate endoscopic activity in the future. Reprocessing of masks is possible and, as such, is warranted in the current situation. Although many practices and outpatient clinics do not have the necessary tools to provide safe reprocessing, cooperation with nearby hospitals and laboratories might be an option to reduce the impact of current PPE scarcity.
  6 in total

1.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  Virological assessment of hospitalized patients with COVID-2019.

Authors:  Roman Wölfel; Victor M Corman; Wolfgang Guggemos; Michael Seilmaier; Sabine Zange; Marcel A Müller; Daniela Niemeyer; Terry C Jones; Patrick Vollmar; Camilla Rothe; Michael Hoelscher; Tobias Bleicker; Sebastian Brünink; Julia Schneider; Rosina Ehmann; Katrin Zwirglmaier; Christian Drosten; Clemens Wendtner
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

3.  COVID-19 and the gastrointestinal tract: more than meets the eye.

Authors:  Siew C Ng; Herbert Tilg
Journal:  Gut       Date:  2020-04-09       Impact factor: 23.059

4.  Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy.

Authors:  Alessandro Repici; Fabio Pace; Roberto Gabbiadini; Matteo Colombo; Cesare Hassan; Marco Dinelli
Journal:  Gastroenterology       Date:  2020-04-10       Impact factor: 22.682

5.  Evidence for Gastrointestinal Infection of SARS-CoV-2.

Authors:  Fei Xiao; Meiwen Tang; Xiaobin Zheng; Ye Liu; Xiaofeng Li; Hong Shan
Journal:  Gastroenterology       Date:  2020-03-03       Impact factor: 22.682

6.  Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States.

Authors:  Yael R Nobel; Meaghan Phipps; Jason Zucker; Benjamin Lebwohl; Timothy C Wang; Magdalena E Sobieszczyk; Daniel E Freedberg
Journal:  Gastroenterology       Date:  2020-04-12       Impact factor: 22.682

  6 in total
  7 in total

1.  Impact of the COVID-19 pandemic on an interdisciplinary endoscopy unit in a German "hotspot" area: a single center experience.

Authors:  Dörte Wichmann; Naushad Bijoy Atique; Dietmar Stüker; Stefano Fusco; Ulrike Schempf; Julia M Grottenthaler; Michael Böckeler; Christian Thiel; Lars Zender; Alfred Königsrainer; Nisar P Malek; Christoph R Werner
Journal:  Surg Endosc       Date:  2020-11-02       Impact factor: 4.584

2.  German bronchoscopy unit readiness for the COVID-19 pandemic: a nationwide survey.

Authors:  Clara S Heidemann; Jakob Garbe; Marko Damm; Steffen Walter; Patrick Michl; Jonas Rosendahl; Kaid Darwiche; Stephan Eisenmann
Journal:  ERJ Open Res       Date:  2020-08-31

Review 3.  [Consequences of the COVID-19/SARS-CoV-2 pandemic for gastroenterology in Germany].

Authors:  Thomas Frieling
Journal:  Gastroenterologe       Date:  2020-10-27

4.  Appropriateness of high-priority criteria and safety of endoscopy procedures during the COVID-19 lockdown.

Authors:  Dalia Morales-Arraez; Anjara Hernández; Alberto Hernández-Bustabad; Carla Amaral; Cristina Reygosa; David Nicolás-Pérez; Antonio Zebenzui Gimeno-García; Manuel Hernández-Guerra
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

5.  Analysis of the effects of the first and second/third waves of the COVID-19 pandemic on an Interdisciplinary Endoscopy Unit in a German 'hotspot' area: a single-center experience.

Authors:  Dörte Wichmann; Ulrike Schempf; Siri Göpel; Dietmar Stüker; Stefano Fusco; Alfred Königsrainer; Nisar P Malek; Christoph R Werner
Journal:  Therap Adv Gastroenterol       Date:  2022-03-23       Impact factor: 4.409

6.  Coronavirus Disease 2019 (COVID-19) Pandemic and Lacrimal Practice: Diagnostic and Therapeutic Nasal Endoscopy and Dacryoendoscopy.

Authors:  Mohammad Javed Ali
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2020 Jul/Aug       Impact factor: 2.011

7.  [Challenges of the COVID-19 pandemic in gastrointestinal endoscopy: expectations and implementation of recommendations].

Authors:  Marko Damm; Jakob Garbe; Stephan Eisenmann; Clara Heidemann; Sebastian Krug; Steffen Walter; Frank Lammert; Patrick Michl; Jonas Rosendahl
Journal:  Z Gastroenterol       Date:  2020-09-16       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.